New drug DF5112 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests a new drug, DF5112, in 48 healthy adults to see if it is safe and how the body handles it. Participants receive a single dose of the drug or a placebo and are monitored for about a week in a clinic, with follow-up visits for a month. The goal is to ga…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC